AJP - Renal Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 289: F816-F825, 2005; doi:10.1152/ajprenal.00024.2005
0363-6127/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, T.
Right arrow Articles by Sharma, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, T.
Right arrow Articles by Sharma, K.

Reactive oxygen species production via NADPH oxidase mediates TGF-{beta}-induced cytoskeletal alterations in endothelial cells

Taishan Hu,1 Satish P. RamachandraRao,1 Senthuran Siva,1 Cathryn Valancius,1 Yanqing Zhu,1 Kalyankar Mahadev,2 Irene Toh,1 Barry J. Goldstein,2 Marilyn Woolkalis,3 and Kumar Sharma1

The Dorrance Hamilton Research Laboratories, 1Division of Nephrology, 2Division of Endocrinology, Department of Medicine, 3Department of Physiology, Thomas Jefferson University, Philadelphia, Pennsylvania

Submitted 21 January 2005 ; accepted in final form 6 May 2005

Cytoskeletal alterations in endothelial cells have been linked to nitric oxide generation and cell-cell interactions. Transforming growth factor (TGF)-{beta} has been described to affect cytoskeletal rearrangement in numerous cell types; however, the underlying pathway is unclear. In the present study, we found that human umbilical vein endothelial cells (HUVEC) have marked cytoskeletal alterations with short-term TGF-{beta} treatment resulting in filipodia formation and F-actin assembly. The cytoskeletal alterations were blocked by the novel TGF-{beta} type I receptor/ALK5 kinase inhibitor (SB-505124) but not by the p38 kinase inhibitor (SB-203580). TGF-{beta} also induced marked stimulation of reactive oxygen species (ROS) within 5 min of TGF-{beta} exposure. TGF-{beta} stimulation of ROS was mediated by the NAPDH oxidase homolog Nox4 as DPI, an inhibitor of NADPH oxidase, and dominant-negative Nox4 adenovirus blocked ROS production. Finally, inhibition of ROS with ROS scavengers or dominant-negative Nox4 blocked the TGF-{beta} effect on cytoskeleton changes in endothelial cells. In conclusion, our studies show for the first time that TGF-{beta}-induced ROS production in human endothelial cells is via Nox4 and that TGF-{beta} alteration of cytoskeleton in HUVEC is mediated via a Nox4-dependent pathway.

human umbilical vein endothelial cells; cell-cell interactions; cytoskeletal rearrangement; transforming growth factor-{beta}



Address for reprint requests and other correspondence: K. Sharma, Suite 353, Jefferson Alumni Hall, 1020 Locust St., Thomas Jefferson Univ., Philadelphia, PA 19107 (e-mail: Kumar.Sharma{at}jefferson.edu)




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. Xia, Q. Meng, L.-Z. Liu, Y. Rojanasakul, X.-R. Wang, and B.-H. Jiang
Reactive Oxygen Species Regulate Angiogenesis and Tumor Growth through Vascular Endothelial Growth Factor
Cancer Res., November 15, 2007; 67(22): 10823 - 10830.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Orient, A. Donko, A. Szabo, T. L. Leto, and M. Geiszt
Novel sources of reactive oxygen species in the human body
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1281 - 1288.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Bedard and K.-H. Krause
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Physiol Rev, January 1, 2007; 87(1): 245 - 313.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
L. Moldovan, K. Mythreye, P. J. Goldschmidt-Clermont, and L. L. Satterwhite
Reactive oxygen species in vascular endothelial cell motility. Roles of NAD(P)H oxidase and Rac1
Cardiovasc Res, July 15, 2006; 71(2): 236 - 246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Geiszt
NADPH oxidases: New kids on the block
Cardiovasc Res, July 15, 2006; 71(2): 289 - 299.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.